Antipicornaviral compounds and compositions, their uses, and materials for their synthesis
申请人:——
公开号:US20030225042A1
公开(公告)日:2003-12-04
Compounds of the formula:
1
where the formula variables are as defined in the disclosure, advantageously inhibit or block the biological activity of the picornaviral 3C protease. These compounds, as well as pharmaceutical compositions containing these compounds, are useful for treating patients or hosts infected with one or more picornaviruses, such as RVP. Intermediates and synthetic methods for preparing such compounds are also described.
ANTIPICORNAVIRAL COMPOUNDS AND COMPOSITIONS, THEIR PHARMACEUTICAL USES, AND MATERIALS FOR THEIR SYNTHESIS
申请人:AGOURON PHARMACEUTICALS, INC.
公开号:EP1274682A2
公开(公告)日:2003-01-15
US6610730B2
申请人:——
公开号:US6610730B2
公开(公告)日:2003-08-26
US6872745B2
申请人:——
公开号:US6872745B2
公开(公告)日:2005-03-29
[EN] ANTIPICORNAVIRAL COMPOUNDS AND COMPOSITIONS, THEIR PHARMACEUTICAL USES, AND MATERIALS FOR THEIR SYNTHESIS<br/>[FR] COMPOSES ET COMPOSITIONS ANTIPICORNAVIRALES, LEURS UTILISATIONS PHARMACEUTIQUES ET MATERIAUX POUR LEUR SYNTHESE
申请人:AGOURON PHARMA
公开号:WO2001079167A2
公开(公告)日:2001-10-25
Compounds of the formula (I) where the formula variables are as defined in the disclosure, advantageously inhibit or block the biological activity of the picornaviral 3C protease. These compounds, as well as pharmaceutical compositions containing these compounds, are useful for treating patients or hosts infected with one or more picornaviruses, such as RVP. Intermediates and synthetic methods for preparing such compounds are also described.